Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_assertion type Assertion NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_head.
- NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_assertion description "[(1) The positive expression rates of Cx43 and E-cadherin protein were higher in the adjacent normal tissues than those in the primary lung carcinoma tissues; (2) the positive expression rates of Cx43 and E-cadherin protein decreased with NSCLC progression; (3) the expression of E-cadherin protein was not related with the pathological type of NSCLC; and (4) the relative quantity of the Cx43 or E-cadherin mRNA expression was correlated with the the histological type, clinical stage, cancer cell differentiation and the lymph node metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_provenance.
- NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_assertion evidence source_evidence_literature NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_provenance.
- NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_assertion SIO_000772 23621211 NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_provenance.
- NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_assertion wasDerivedFrom befree-2016 NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_provenance.
- NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_assertion wasGeneratedBy ECO_0000203 NP1072586.RAIshnJaPEmVYm_6YQ2Heap9a7L39mpzVm5NeRd_3zpeo130_provenance.